| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.81B | 6.58B | 6.49B | 5.94B | 4.97B |
| Gross Profit | 900.00M | 1.05B | 1.04B | 1.01B | 820.10M |
| EBITDA | 35.00M | 198.00M | 295.00M | 300.29M | 214.32M |
| Net Income | -7.00M | 91.00M | 171.00M | 179.35M | 124.08M |
Balance Sheet | |||||
| Total Assets | 2.20B | 2.60B | 2.12B | 2.04B | 1.75B |
| Cash, Cash Equivalents and Short-Term Investments | 660.00M | 1.05B | 709.00M | 765.90M | 607.60M |
| Total Debt | 435.00M | 435.00M | 427.00M | 424.99M | 433.59M |
| Total Liabilities | 2.16B | 2.50B | 2.03B | 1.96B | 1.75B |
| Stockholders Equity | 46.00M | 97.00M | 94.00M | 81.28M | -1.77M |
Cash Flow | |||||
| Free Cash Flow | -309.00M | 482.00M | 158.37M | 317.36M | 227.25M |
| Operating Cash Flow | -278.00M | 520.00M | 198.49M | 347.69M | 260.15M |
| Investing Cash Flow | -31.00M | -38.00M | -21.73M | -32.12M | -31.01M |
| Financing Cash Flow | -90.00M | -173.00M | -155.01M | -141.15M | -208.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $3.11B | 12.08 | 13.89% | 2.89% | 3.65% | 5.71% | |
66 Neutral | $795.90M | 14.91 | 24.08% | 0.88% | 9.64% | 9.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $2.39B | 17.80 | 10.02% | 8.65% | -7.27% | -43.88% | |
51 Neutral | $1.20B | -89.53 | -0.64% | 4.96% | -2.44% | -156.01% | |
48 Neutral | $1.63B | 10.87 | 111.30% | 1.81% | 0.99% | -47.02% | |
43 Neutral | $834.93M | -117.01 | -9.79% | 6.37% | 3.19% | -86.21% |
On February 10, 2026, Insperity announced a Realignment Plan that will eliminate about 4% of its non-sales roles as part of an internal reorganization aimed at boosting efficiency and sharpening focus on key business areas, with an estimated $9 million in one-time severance and related charges largely recognized in the first quarter of 2026 and excluded from non-GAAP metrics. The company also reported a 2025 net loss of $7 million despite 4% revenue growth to $6.8 billion and modest WSEE gains, as elevated benefits costs pressured margins, prompting management to emphasize margin recovery, cost efficiencies and disciplined hiring, while returning $109 million to shareholders in 2025 and issuing 2026 guidance that points to a planned rebound in adjusted EBITDA and earnings.
The most recent analyst rating on (NSP) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Insperity stock, see the NSP Stock Forecast page.
On December 15, 2025, Insperity, Inc. announced an Eighth Amendment to its Amended and Restated Credit Agreement with Zions Bancorporation, N.A. dba Amegy Bank and other lenders. This amendment increases the borrowing capacity under its revolving credit facility from $650 million to $750 million, with a potential increase to $800 million, extends the maturity date to December 15, 2028, and adjusts financial covenants, potentially enhancing Insperity’s financial flexibility and operational capacity.
The most recent analyst rating on (NSP) stock is a Hold with a $36.00 price target. To see the full list of analyst forecasts on Insperity stock, see the NSP Stock Forecast page.